Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study

Abstract

We found that a whey protein supplement decreased the postprandial chylomicron response compared with casein in persons with abdominal obesity, thereby indicating a beneficial impact on CVD risk. This trial was registered at clinicaltrials.gov as NCT01472666.

Whey and Casein Proteins and Medium-Chain Saturated Fatty Acids from Milk Do Not Increase Low-Grade Inflammation in Abdominally Obese Adults

“…The present study is part of the DairyHealth Study that investigates the effects of MC-SFA and milk protein on postprandial lipemia [24]. The study was carried out at the Departments of Endocrinology and Internal Medicine, Aarhus University Hospital, between October 2011 and December 2012.…”

“…The DairyHealth Study design and population have been described in detail previously [24]. In short, the study was a 12-week, randomized, double-blinded, parallel-controlled, diet intervention study.…”

“…The difference in fatty acid composition in the 2 types of butter was obtained by using a targeted cattle feeding regimen (for further details, see earlier study [24]). The study participants were advised to keep their body weight constant, and not to change their physical activity level, smoking habits, alcohol consumption, and drug treatment during the study.…”

“…Dietary guidance was given on how to include the test supplementation in the participants' habitual nutrition. Dietary records were obtained before and at the end of the 12-week study (for further details, see earlier study [24]). As described earlier [24], we screened 74 and randomized 63 individuals; 52 participants completed the study.…”

“…Dietary records were obtained before and at the end of the 12-week study (for further details, see earlier study [24]). As described earlier [24], we screened 74 and randomized 63 individuals; 52 participants completed the study. The inclusion criteria were age ≥18 years, abdominal obesity (waist circumference of ≥94 cm for men and ≥80 cm for women), and weight stability.…”